{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T17:26:20Z","timestamp":1776187580310,"version":"3.50.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01-DK121970"],"award-info":[{"award-number":["R01-DK121970"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.livres.2023.09.001","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:49:47Z","timestamp":1694551787000},"page":"177-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Small-molecule chemical probes for the potential therapeutic targets in alcoholic liver diseases"],"prefix":"10.1016","volume":"7","author":[{"given":"Ashish","family":"Dogra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9680-4614","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2023.09.001_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","article-title":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2023.09.001_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphys.2012.00193","article-title":"Acute alcohol-induced liver injury","volume":"3","author":"Massey","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.livres.2023.09.001_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119328","article-title":"A\u00a0review on molecular mechanism of alcoholic liver disease","volume":"274","author":"Namachivayam","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2023.09.001_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.35946\/arcr.v42.1.13","article-title":"Alcohol use disorder and alcohol-associated liver disease","volume":"42","author":"Ramkissoon","year":"2022","journal-title":"Alcohol Res"},{"key":"10.1016\/j.livres.2023.09.001_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.livres.2023.09.001_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open\u00adlabel, dose\u00adescalation study to assess the safety and efficacy of il\u00ad22 agonist f\u00ad652 in patients with alcohol\u00adassociated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/cells12010022","article-title":"Current therapeutic options and potential of mesenchymal stem cell therapy for alcoholic liver disease","volume":"12","author":"Han","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.livres.2023.09.001_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.694475","article-title":"Natural compounds: a potential treatment for alcoholic liver disease?","volume":"12","author":"Yan","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2023.09.001_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.toxlet.2015.03.002","article-title":"Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease","volume":"234","author":"Zhao","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.livres.2023.09.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.livres.2022.09.004","article-title":"New insights in the pathogenesis of alcohol-related liver disease: the metabolic, immunologic, and neurologic pathways","volume":"7","author":"Ryu","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2023.09.001_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.livres.2023.03.002","article-title":"Current and emerging therapies for alcohol-associated hepatitis","volume":"7","author":"Idalsoaga","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2023.09.001_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.livres.2023.09.001_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.livres.2018.11.002","article-title":"Alcoholic liver disease: a current molecular and clinical perspective","volume":"2","author":"Ohashi","year":"2018","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2023.09.001_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"Cederbaum","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2023.09.001_bib18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2023.09.001_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc2191","article-title":"Molecular mechanisms of alcohol-mediated carcinogenesis","volume":"7","author":"Seitz","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.livres.2023.09.001_bib20","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","article-title":"CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis","volume":"63","author":"Aff\u00f2","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.livres.2023.09.001_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5009\/gnl16477","article-title":"Pathophysiology and management of alcoholic liver disease: update 2016","volume":"11","author":"Stickel","year":"2017","journal-title":"Gut liver"},{"key":"10.1016\/j.livres.2023.09.001_bib22","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0891-5849(01)00748-1","article-title":"The role of Kupffer cell oxidant production in early ethanol-induced liver disease","volume":"31","author":"Wheeler","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.livres.2023.09.001_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep.22978","article-title":"Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/acer.13546","article-title":"Carcinogenic etheno DNA adducts in alcoholic liver disease: correlation with cytochrome P-4502E1 and fibrosis","volume":"42","author":"Mueller","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.livres.2023.09.001_bib25","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0016-5085(03)00276-2","article-title":"Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice","volume":"124","author":"Ji","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1530-0277.2008.00827.x","article-title":"Molecular mechanisms of alcoholic fatty liver","volume":"33","author":"Purohit","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.livres.2023.09.001_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/CBI20090130","article-title":"Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis","volume":"34","author":"Tatsukawa","year":"2010","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.livres.2023.09.001_bib28","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/ijms20112712","article-title":"Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease","volume":"20","author":"Kong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2023.09.001_bib29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1530-0277.2009.01141.x","article-title":"Anti\u00adinflammatory and anti\u00adapoptotic roles of endothelial cell STAT3 in alcoholic liver injury","volume":"34","author":"Miller","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.livres.2023.09.001_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2022.08.022","article-title":"IL-6\/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease","volume":"78","author":"Park","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1194\/jlr.R119000547","article-title":"Alcohol effects on hepatic lipid metabolism","volume":"61","author":"Jeon","year":"2020","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.livres.2023.09.001_bib32","doi-asserted-by":"crossref","first-page":"32443","DOI":"10.1073\/pnas.2011442117","article-title":"Direct lysosome-based autophagy of lipid droplets in hepatocytes","volume":"117","author":"Schulze","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.09.001_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep4.1056","article-title":"Hepatic lipophagy: new insights into autophagic catabolism of lipid droplets in the liver","volume":"1","author":"Schulze","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2023.09.001_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev-nutr-071813-105336","article-title":"Autophagy and lipid droplets in the liver","volume":"35","author":"Martinez-Lopez","year":"2015","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.livres.2023.09.001_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib36","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","article-title":"Kupffer cells: inflammation pathways and cell-cell interactions in alcohol-associated liver disease","volume":"190","author":"Slevin","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2023.09.001_bib37","first-page":"G518","article-title":"Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol","volume":"269","author":"Maher","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.livres.2023.09.001_bib38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22680","article-title":"The interleukin-17 pathway is involved in human alcoholic liver disease","volume":"49","author":"Lemmers","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib39","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.gastro.2017.09.022","article-title":"MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease","volume":"154","author":"Satishchandran","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.35946\/arcr.v37.2.04","article-title":"Impact of alcohol abuse on the adaptive immune system","volume":"37","author":"Pasala","year":"2015","journal-title":"Alcohol Res"},{"key":"10.1016\/j.livres.2023.09.001_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hep.27036","article-title":"Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice","volume":"60","author":"Kwon","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib43","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib44","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.3748\/wjg.v12.i43.6926","article-title":"Role of ethanol in the regulation of hepatic stellate cell function","volume":"12","author":"Wang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2023.09.001_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib46","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2007.09.034","article-title":"Abrogation of the antifibrotic effects of natural killer cells\/interferon-gamma contributes to alcohol acceleration of liver fibrosis","volume":"134","author":"Jeong","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/IJPSYM.IJPSYM_356_17","article-title":"A\u00a0comparative study of factors associated with relapse in alcohol dependence and opioid dependence","volume":"39","author":"Kadam","year":"2017","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.livres.2023.09.001_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jhep.2008.10.020","article-title":"The impact of CYP2E1 on the development of alcoholic liver disease as studied in a transgenic mouse model","volume":"50","author":"Butura","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/biomedicines6040106","article-title":"Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects","volume":"6","author":"Teschke","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2023.09.001_bib51","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.3390\/biom5042659","article-title":"Autophagy protects against CYP2E1\/chronic ethanol-induced hepatotoxicity","volume":"5","author":"Lu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.livres.2023.09.001_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0741-8329(02)00232-X","article-title":"Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium","volume":"27","author":"Purohit","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.livres.2023.09.001_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2014.08.009","article-title":"Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver","volume":"222","author":"Chen","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.livres.2023.09.001_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1530-0277.2006.00063.x","article-title":"Silymarin protects against acute ethanol-induced hepatotoxicity in mice","volume":"30","author":"Song","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 1","key":"10.1016\/j.livres.2023.09.001_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","article-title":"Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis","volume":"28","author":"Roh","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acer.12704","article-title":"Alcoholic liver disease: the gut microbiome and liver cross talk","volume":"39","author":"Hartmann","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.livres.2023.09.001_bib57","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fimmu.2020.01210","article-title":"Increasing the chemical variety of small-molecule-based TLR4 modulators: an overview","volume":"11","author":"Romerio","year":"2010","journal-title":"Front Immunol"},{"key":"10.1016\/j.livres.2023.09.001_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/710381","article-title":"Toll-like receptors in the pathogenesis of alcoholic liver disease","volume":"2010","author":"Petrasek","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.livres.2023.09.001_bib59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3390\/nu10070855","article-title":"Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective","volume":"10","author":"Farzaei","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2023.09.001_bib60","first-page":"192","article-title":"Ursodeoxycholic acid in treatment of non-cholestatic liver diseases: a systematic review","volume":"4","author":"Reardon","year":"2016","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4287890","article-title":"Resveratrol ameliorates experimental alcoholic liver disease by modulating oxidative stress","volume":"2017","author":"Peiyuan","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.livres.2023.09.001_bib62","first-page":"699","article-title":"Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine","volume":"26","author":"Colell","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI117306","article-title":"Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes","volume":"94","author":"Garc\u00eda-Ruiz","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.09.001_bib64","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.bbadis.2015.09.014","article-title":"Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK","volume":"1852","author":"Kim","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2023.09.001_bib65","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of alcoholic liver disease: role of oxidative metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2023.09.001_bib66","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.3390\/ijms22105170","article-title":"Alcohol-related liver disease: basic mechanisms and clinical perspectives","volume":"22","author":"Liu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2023.09.001_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136496","article-title":"Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1\/p38MAPK\u03b1-dependent mechanisms","volume":"5","author":"Ma","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.livres.2023.09.001_bib68","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jgh.16087","article-title":"Mechanism of ASK1 involvement in liver diseases and related potential therapeutic targets: a critical pathway molecule worth investigating","volume":"38","author":"Chen","year":"2023","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-020-01878-y","article-title":"ASK1 inhibition: a therapeutic strategy with multi-system benefits","volume":"98","author":"Ogier","year":"2020","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.livres.2023.09.001_bib70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0040-1713115","article-title":"Nonalcoholic steatohepatitis promoting kinases","volume":"40","author":"Ibrahim","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2023.09.001_bib71","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib72","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41575-021-00444-2","article-title":"Regulation and functional roles of chemokines in liver diseases","volume":"18","author":"Cao","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib73","doi-asserted-by":"crossref","first-page":"30","DOI":"10.21037\/dmr-21-87","article-title":"Role of the chemokine system in liver fibrosis: a narrative review","volume":"5","author":"Poulsen","year":"2022","journal-title":"Dig Med Res"},{"key":"10.1016\/j.livres.2023.09.001_bib74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjp.2008.270","article-title":"Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice","volume":"155","author":"Zarbock","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.livres.2023.09.001_bib75","doi-asserted-by":"crossref","first-page":"G773","DOI":"10.1152\/ajpgi.00080.2019","article-title":"Cell-specific regulatory effects of CXCR2 on cholestatic liver injury","volume":"317","author":"Konishi","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2023.09.001_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151765","article-title":"Impact of a CXCL12\/CXCR4 antagonist in bleomycin (BLM) induced pulmonary fibrosis and carbon tetrachloride (CCl4) induced hepatic fibrosis in mice","volume":"11","author":"Chow","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2023.09.001_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/srep28806","article-title":"The cannabinoid receptor 2 protects against alcoholic liver disease via a macrophage autophagy-dependent pathway","volume":"6","author":"Dena\u00ebs","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2023.09.001_bib78","doi-asserted-by":"crossref","first-page":"G649","DOI":"10.1152\/ajpgi.90352.2008","article-title":"Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis","volume":"295","author":"Moezi","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2023.09.001_bib79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2023.09.001_bib80","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/bph.15010","article-title":"The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor\/\u03b2-arrestin1\/Akt pathway","volume":"177","author":"Tan","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.livres.2023.09.001_bib81","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib82","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","article-title":"Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6","volume":"152","author":"Lai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.09.001_bib83","article-title":"Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis","volume":"3","author":"Bhattacharya","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2023.09.001_bib84","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2023.09.001_bib85","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/acsptsci.8b00003","article-title":"Inhibition of hepatotoxicity by a LXR inverse agonist in a model of alcoholic liver disease","volume":"1","author":"Sengupta","year":"2018","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.livres.2023.09.001_bib86","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.toxlet.2022.02.002","article-title":"A\u00a0biologically based model to quantitatively assess the role of the nuclear receptors liver X (LXR), and pregnane X (PXR) on chemically induced hepatic steatosis","volume":"359","author":"Bay","year":"2022","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.livres.2023.09.001_bib87","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1194\/jlr.M900037-JLR200","article-title":"LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse","volume":"50","author":"Quinet","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.livres.2023.09.001_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108778","article-title":"Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease","volume":"113","author":"Ni","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.livres.2023.09.001_bib89","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.livres.2023.09.001_bib90","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2023.09.001_bib91","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00535-021-01803-1","article-title":"STING and liver disease","volume":"56","author":"Chen","year":"2021","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2023.09.001_bib92","article-title":"Intervention of cGAS-STING signaling in sterile inflammatory diseases","volume":"14","author":"Hong","year":"2022","journal-title":"J\u00a0Mol Cell Biol"},{"key":"10.1016\/j.livres.2023.09.001_bib93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0038-1676806","article-title":"Inflammation and liver cancer: molecular mechanisms and therapeutic targets","volume":"39","author":"Yang","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2023.09.001_bib94","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1308331110","article-title":"STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease","volume":"110","author":"Petrasek","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.09.001_bib95","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2023.09.001_bib96","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.1911870117","article-title":"Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation","volume":"117","author":"Luther","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.09.001_bib97","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.24059","article-title":"Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells","volume":"53","author":"Petrasek","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.09.001_bib98","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jhep.2019.01.021","article-title":"The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice","volume":"70","author":"Sanz-Garcia","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101274","article-title":"Autophagic degradation of IRF3 induced by the small-molecule auranofin inhibits its transcriptional and proapoptotic activities","volume":"297","author":"Glanz","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2023.09.001_bib100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/jcp.26938","article-title":"MicroRNAs in alcoholic liver disease: recent advances and future applications","volume":"234","author":"Xu","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.livres.2023.09.001_bib101","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/toxins13120910","article-title":"Aurintricarboxylic acid decreases RNA toxicity in a C. elegans model of repeat expansions","volume":"13","author":"Braun","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.livres.2023.09.001_bib102","first-page":"1673","article-title":"MiR-370 promotes apoptosis in colon cancer by directly targeting MDM4","volume":"15","author":"Shen","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.livres.2023.09.001_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24508","article-title":"Arctigenin inhibits apoptosis, extracellular matrix degradation, and inflammation in human nucleus pulposus cells by up-regulating miR-483-3p","volume":"36","author":"Ji","year":"2022","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.livres.2023.09.001_bib104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14218\/JCTH.2015.00008","article-title":"Diagnosis and management of alcoholic liver disease","volume":"3","author":"Dugum","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2023.09.001_bib108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-4731(87)90370-0","article-title":"Synthesis, biologic activity, and protein binding characteristics of a new vitamin D analog, 22-hydroxyvitamin D3","volume":"28","author":"Gill","year":"1987","journal-title":"J\u00a0Steroid Biochem"},{"key":"10.1016\/j.livres.2023.09.001_bib109","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbrc.2013.11.057","article-title":"Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease","volume":"443","author":"Wu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2023.09.001_bib111","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.31321","article-title":"Inhibition of sphingosine-1-phosphate-induced Th17 cells ameliorates alcohol\u00adassociated steatohepatitis in mice","volume":"73","author":"Chu","year":"2021","journal-title":"Hepatology"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:49Z","timestamp":1762872409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568423000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2542568423000466"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2023.09.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule chemical probes for the potential therapeutic targets in alcoholic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2023.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}